18F-FDG PET/CT of thymic epithelial tumors: Usefulness for distinguishing and staging tumor subgroups

Journal of Nuclear Medicine

Volumn 47, Issue 10, 2006, Pages 1628-1634

  Yon, Mi Sung ^a,b   Kyung, Soo Lee ^a   Kim, Byung Tae ^a   Joon, Young Choi ^a   Young, Mog Shim ^a   Yi, Chin A ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Eulji University School of Medicine   (South Korea)

Author keywords

18F FDG; PET CT; Thymic neoplasms; Thymoma; Thymus

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18; IOMEPROL; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER INVASION; CANCER RISK; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; DRUG UPTAKE; FEMALE; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; MEDIASTINUM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; THYMOMA; TUMOR DIFFERENTIATION; ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; CARCINOMA; MIDDLE AGED; RADIOGRAPHY; SCINTISCANNING; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, MUCOEPIDERMOID; CARCINOMA, NEUROENDOCRINE; CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; THYMOMA; THYMUS NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 35148875181     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Travis W, Brambilla E, Müller-Hermelink H, et al. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Paris, France: Oxford University Press; 2004.
2. Chen G, Marx A, Wen-Hu C, et al. New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China. Cancer. 2002;95:420-429.
3. Jung KJ, Lee KS, Han J, et al. Malignant thymic epithelial tumors: CTpathologic correlation. AJR. 2001;176:433-439.
4. Jeong YJ, Lee KS, Kim J, et al. Does CT of thymic epithelial tumors enable us to differentiate histologic subtypes and predict prognosis? AJR. 2004;183:283-289.
5. Tomiyama N, Johkoh T, Mihara N, et al. Using the World Health Organization classification of thymic epithelial neoplasms to describe CT findings. AJR. 2002;179:881-886.
6. Sakai F, Sone S, Kiyono K, et al. MR imaging of thymoma: radiologic-pathologic correlation. AJR. 1992;158:751-756.
7. Beyer T, Townsend DW, Brun T, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med. 2000;41:1369-1379.
8. Townsend DW, Beyer T, Blodgett TM. PET/CT scanners: a hardware approach to image fusion. Semin Nucl Med. 2003;33:193-204.
9. Townsend DW. A combined PET/CT scanner: the choices. J Nucl Med. 2001;42:533-534.
10. Liu RS, Yeh SH, Huang MH, et al. Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of thymoma: a preliminary report. Eur J Nucl Med. 1995;22:1402-1407.
11. 11C-methionine PET and FDG PET. J Nucl Med. 1999;40:1595-1601.
12. Kubota K, Yamada S, Kondo T, et al. PET imaging of primary mediastinal tumours. Br J Cancer. 1996;73:882-886.
13. Masaoka A, Monden Y, Nakahara K, et al. Follow-up study of thymomas with special reference to their clinical stages. Cancer. 1981;48:2485-2492.
14. Yamakawa Y, Masaoka A, Hashimoto T, et al. A tentative tumor-node-metastasis classification of thymoma. Cancer. 1991;68:1984-1987.
15. Okumura M, Miyoshi S, Fujii Y, et al. Clinical and functional significance of WHO classification on human thymic epithelial neoplasms: a study of 146 consecutive tumors. Am J Surg Pathol. 2001;25:103-110.
16. Okumura M, Ohta M, Tateyama H, et al. The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients. Cancer. 2002;94:624-632.
17. Fang W, Chen W, Chen G, et al. Surgical management of thymic epithelial tumors: a retrospective review of 204 cases. Ann Thorac Surg. 2005;80:2002-2007.
18. Nonaka T, Tamaki Y, Higuchi K, et al. The role of radiotherapy for thymic carcinoma. Jpn J Clin Oncol. 2004;34:722-726.
19. Kato D, Achiwa H, Sato S, et al. A case of thymic carcinoma responding to combination chemotherapy with nedaplatin, etoposide, and ifosfamide [in Japanese]. Gan To Kagaku Ryoho. 2005;32:377-379.
20. Kaira K, Watanabe R, Takise A, et al. Thymic cancer effectively treated by combination chemotherapy of carboplatin and etoposide with concurrent radiotherapy [in Japanese]. Gan To Kagaku Ryoho. 2005;32:1989-1992.
21. Han J, Lee KS, Yi CA, et al. Thymic epithelial tumors classified according to a newly established WHO scheme: CT and MR findings. Korean J Radiol. 2003;4:46-53.
22. Kubota R, Kubota K, Yamada S, et al. Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG. J Nucl Med. 1995;36:484-492.
23. 125I seeds. Stereotact Funct Neurosurg. 1997;69:129-135.